We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-17.1%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
-$1.36B
(-19%)
Cap. Flow
-$72.7M
Cap. Flow
% of AUM
-1.28%
Top 10 Holdings %
Top 10 Hldgs %
17.58%
Holding
1,139
New
165
Increased
376
Reduced
380
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$58.3M |
| 2 |
CELG
Celgene Corp
CELG
|
+$27.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$23.3M |
| 4 |
TJX Companies
TJX
|
+$23.1M |
| 5 |
Synopsys
SNPS
|
+$19.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dell
DELL
|
+$45.2M |
| 2 |
Rockwell Automation
ROK
|
+$25.3M |
| 3 |
Accenture
ACN
|
+$24M |
| 4 |
Visteon
VC
|
+$23.4M |
| 5 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$22.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.85% |
| 2 | Financials | 17.71% |
| 3 | Consumer Discretionary | 12.6% |
| 4 | Healthcare | 11.49% |
| 5 | Industrials | 11.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Ecolab
ECL
$76.4B
| $872K | 0.02% |
5,920
| – | – |
|
|
HEES
627
DELISTED
H&E Equipment Services
HEES
| $868K | 0.02% |
42,490
-33,527
| -44% | -$821K |
|
|
MODV
628
DELISTED
ModivCare
MODV
| $867K | 0.02% |
14,442
-35,418
| -71% | -$2.35M |
|
|
ONCE
629
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $863K | 0.02% |
+22,040
| New | +$956K |
|
630
Urban Outfitters
URBN
$6.22B
| $859K | 0.02% |
25,880
-2,820
| -10% | -$105K |
|
631
Lazard
LAZ
$4.23B
| $857K | 0.02% |
23,220
-24,840
| -52% | -$991K |
|
632
Standex International
SXI
$3.75B
| $855K | 0.02% |
+12,728
| New | +$1.07M |
|
|
OMN
633
DELISTED
OMNOVA Solutions Inc.
OMN
| $854K | 0.02% |
116,573
+53,119
| +84% | +$428K |
|
634
First Financial Corp
THFF
$924M
| $849K | 0.01% |
21,147
-6,853
| -24% | -$315K |
|
|
ATRS
635
DELISTED
Antares Pharma, Inc.
ATRS
| $847K | 0.01% |
+311,400
| New | +$1.03M |
|
|
SP
636
DELISTED
SP Plus Corporation
SP
| $845K | 0.01% |
+28,594
| New | +$886K |
|
637
Park-Ohio Holdings
PKOH
$563M
| $840K | 0.01% |
27,357
+220
| +0.8% | +$7.68K |
|
638
Zumiez
ZUMZ
$328M
| $827K | 0.01% |
+43,120
| New | +$913K |
|
639
Procter & Gamble
PG
$346B
| $826K | 0.01% |
8,990
-53,382
| -86% | -$4.77M |
|
640
Wendy's
WEN
$1.39B
| $824K | 0.01% |
52,800
+6,700
| +15% | +$114K |
|
|
ITCI
641
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $820K | 0.01% |
72,014
+61,389
| +578% | +$991K |
|
642
Peapack-Gladstone Financial
PGC
$833M
| $815K | 0.01% |
32,354
-19,474
| -38% | -$537K |
|
|
BFX
643
DELISTED
BowFlex Inc.
BFX
| $812K | 0.01% |
74,477
-27,480
| -27% | -$344K |
|
644
Curtiss-Wright
CW
$27.5B
| $805K | 0.01% |
7,878
+990
| +14% | +$111K |
|
|
AGR
645
DELISTED
Avangrid, Inc.
AGR
| $798K | 0.01% |
15,940
-124,634
| -89% | -$6.13M |
|
|
DSPG
646
DELISTED
DSP Group Inc
DSPG
| $796K | 0.01% |
71,057
-3,918
| -5% | -$45.8K |
|
647
Globus Medical
GMED
$10.6B
| $786K | 0.01% |
18,170
-39,493
| -68% | -$1.97M |
|
648
Exelixis
EXEL
$14B
| $785K | 0.01% |
39,890
-200
| -0.5% | -$3.57K |
|
|
XHR
649
Xenia Hotels & Resorts
XHR
$2B
| $781K | 0.01% |
45,434
+1,200
| +3% | +$24.4K |
|
|
AAMI
650
Acadian Asset Management
AAMI
$2.95B
| $774K | 0.01% |
72,433
-12,232
| -14% | -$147K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2018 Portfolio in Review
As of Q4 2018, Jacobs Levy Equity Management held 1,139 positions worth $5.69B, down 19% from $7.05B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Jacobs Levy Equity Management's Q4 2018 filing shows 165 new, 376 increased, 380 reduced and 175 closed positions. Its largest new stake was Starbucks: 930,980 shares worth $60M. The largest sale was Dell, an estimated $45.2M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q4 2018 buy was Starbucks: 930,980 shares worth $60M.
- Jacobs Levy Equity Management added most to Celgene Corp in Q4 2018, an estimated $27.6M increase.
- Jacobs Levy Equity Management's biggest Q4 2018 reduction was Accenture, cutting an estimated $24M.
- Jacobs Levy Equity Management fully exited Dell in Q4 2018, selling an estimated $45.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 18% of its $5.69B portfolio in Q4 2018.
- Jacobs Levy Equity Management opened 165 new positions and closed 175 in Q4 2018.
- Jacobs Levy Equity Management's portfolio value fell 19% quarter-over-quarter to $5.69B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2018, filed 14 Feb 2019.